These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 33576304)
1. CD155-Prognostic and Immunotherapeutic Implications Based on Multiple Analyses of Databases Across 33 Human Cancers. Zhang H; Yang Z; Du G; Cao L; Tan B Technol Cancer Res Treat; 2021; 20():1533033820980088. PubMed ID: 33576304 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2. Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y Front Immunol; 2023; 14():1155182. PubMed ID: 37275857 [TBL] [Abstract][Full Text] [Related]
3. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures. Zhang X; Wang Y; A G; Qu C; Chen J Front Immunol; 2021; 12():721030. PubMed ID: 34531868 [TBL] [Abstract][Full Text] [Related]
4. The immune suppressive factors CD155 and PD-L1 show contrasting expression patterns and immune correlates in ovarian and other cancers. Smazynski J; Hamilton PT; Thornton S; Milne K; Wouters MCA; Webb JR; Nelson BH Gynecol Oncol; 2020 Jul; 158(1):167-177. PubMed ID: 32446718 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value and immunological role of PDCD1 gene in pan-cancer. Miao Y; Wang J; Li Q; Quan W; Wang Y; Li C; Wu J; Mi D Int Immunopharmacol; 2020 Dec; 89(Pt B):107080. PubMed ID: 33069926 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of an Immune Checkpoint (CD155) in Breast Cancer Associated with Prognostic Significance and Exhausted Tumor-Infiltrating Lymphocytes: A Cohort Study. Li YC; Zhou Q; Song QK; Wang RB; Lyu S; Guan X; Zhao YJ; Wu JP J Immunol Res; 2020; 2020():3948928. PubMed ID: 32411795 [TBL] [Abstract][Full Text] [Related]
7. Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma. Wu L; Mao L; Liu JF; Chen L; Yu GT; Yang LL; Wu H; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ Cancer Immunol Res; 2019 Oct; 7(10):1700-1713. PubMed ID: 31387897 [TBL] [Abstract][Full Text] [Related]
8. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma. Zuo S; Wei M; Wang S; Dong J; Wei J Front Immunol; 2020; 11():1218. PubMed ID: 32714316 [No Abstract] [Full Text] [Related]
9. Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma. Lepletier A; Madore J; O'Donnell JS; Johnston RL; Li XY; McDonald E; Ahern E; Kuchel A; Eastgate M; Pearson SA; Mallardo D; Ascierto PA; Massi D; Merelli B; Mandala M; Wilmott JS; Menzies AM; Leduc C; Stagg J; Routy B; Long GV; Scolyer RA; Bald T; Waddell N; Dougall WC; Teng MWL; Smyth MJ Clin Cancer Res; 2020 Jul; 26(14):3671-3681. PubMed ID: 32345648 [TBL] [Abstract][Full Text] [Related]
10. Large-scale analysis reveals the specific clinical and immune features of CD155 in glioma. Liu F; Huang J; Xiong Y; Li S; Liu Z Aging (Albany NY); 2019 Aug; 11(15):5463-5482. PubMed ID: 31377744 [TBL] [Abstract][Full Text] [Related]
11. The panoramic picture of pepsinogen gene family with pan-cancer. Shen S; Li H; Liu J; Sun L; Yuan Y Cancer Med; 2020 Dec; 9(23):9064-9080. PubMed ID: 33067881 [TBL] [Abstract][Full Text] [Related]
12. Elucidating the pan-oncologic landscape of S100A9: prognostic and therapeutic corollaries from an integrative bioinformatics and Mendelian randomization analysis. Chen Y; Wu Z; Yi X Sci Rep; 2024 Aug; 14(1):19071. PubMed ID: 39154046 [TBL] [Abstract][Full Text] [Related]
13. Special AT-rich Sequence Binding-Protein 1 (SATB1) Correlates with Immune Infiltration in Breast, Head and Neck, and Prostate Cancer. Ge H; Yan Y; Yan M; Guo L; Mao K Med Sci Monit; 2020 Jun; 26():e923208. PubMed ID: 32562536 [TBL] [Abstract][Full Text] [Related]
14. A Comprehensive Pan-Cancer Analysis of 33 Human Cancers Reveals the Immunotherapeutic Value of Aryl Hydrocarbon Receptor. Mo Z; Li P; Cao Z; Zhang S Front Immunol; 2021; 12():564948. PubMed ID: 34290693 [TBL] [Abstract][Full Text] [Related]
15. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers. Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L Front Immunol; 2019; 10():6. PubMed ID: 30761122 [No Abstract] [Full Text] [Related]
16. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker. Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W Front Immunol; 2021; 12():646523. PubMed ID: 33679809 [TBL] [Abstract][Full Text] [Related]
17. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer. Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791 [No Abstract] [Full Text] [Related]
18. Integrated analysis identifies AQP9 correlates with immune infiltration and acts as a prognosticator in multiple cancers. Liu X; Xu Q; Li Z; Xiong B Sci Rep; 2020 Nov; 10(1):20795. PubMed ID: 33247170 [TBL] [Abstract][Full Text] [Related]
19. Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients. Huang Y; Wang FM; Wang T; Wang YJ; Zhu ZY; Gao YT; Du Z Digestion; 2012; 86(4):329-37. PubMed ID: 23207161 [TBL] [Abstract][Full Text] [Related]
20. Tumor intrinsic and extrinsic immune functions of CD155. O'Donnell JS; Madore J; Li XY; Smyth MJ Semin Cancer Biol; 2020 Oct; 65():189-196. PubMed ID: 31883911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]